A/Prof Phumla Sinxadi is a consultant clinical pharmacologist, as well as an Associate Professor of Medicine in the Division of Clinical Pharmacology, University of Cape Town (UCT), South Africa
Phumla teaches clinical pharmacology to undergraduate and postgraduates students at UCT. Her main research interests include i) pharmacokinetics and pharmacogenomics of antiretroviral drugs; ii) gene-gene interactions between antiretroviral and antituberculous drugs, iii) drug development. She was the lead investigator for the First-in-Man clinical trial investigating the safety, tolerability and pharmacokinetics of MMV390048, a novel antimalarial drug discovered at UCT. 1st African First Into Human study for an antimalarial compound for an African led international collaborative project.
She received her PhD degree in Clinical Pharmacology from the University of Cape Town in 2016, a Masters of Medicine in Clinical Pharmacology in 2010, and a Bachelor of Medicine and Surgery degree in 2001. In 2017, she completed a Certificate in Human Pharmacology from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians in the United Kingdom.
After completing her PhD, she spent a year at GlaxoSmithKline (London) as a WHO-TDR Career Development Fellow